knowledge -WSS

knowledge

author：entertainment 2025-10-01 20:14:44 - browse：47

Medicare and money photo illustration. — Adobe

Medical technology lobby AdvaMed is fed up with the Centers for Medicare and Medicaid Services. In a letter sent to the agency and shared with STAT, the group urged CMS to act on finalizing a pathway that would make reimbursement for breakthrough devices easier.

CMS has been working on implementing the pathway since 2021. A CMS spokesperson told STAT the agency is working “expeditiously” to finalize it. Scott Whitaker, CEO of AdvaMed, said the device industry is tired of waiting.

“I myself have begun to wonder if they’re really serious about doing this, or if they’re just saying they’re serious about doing it for political reasons or otherwise,” Whitaker told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Change Healthcare cyberattack outage could last weeks

focus

WSS

Timeline: Key moments in fight for gay rights

How to fix the rural physician shortage in the U.S.

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Biotech companies concerned about China biosecurity crackdown

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

ALS groups 'won't be played again' by the FDA, drug sponsors

Wikipedia

knowledge

Wikipedia

Moonlake's readout produced a cash windfall. Risks remain

Patients, doctors are clashing about side effects of hormonal birth control

BioMarin wins approval for gene therapy to treat hemophilia A

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Medicare proposal to cover medical devices draws a mixed reaction

Biden administration plans revamp of organ transplant system

Tori Bowie and the unacceptable rates of Black maternal death

RSV vaccines may be linked to small increased risk of developing GBS

Walensky prepares to leave CDC — and Congress — behind

Clinical trials giant ICON acquires HumanFirst

entertainment

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Why getting cancer drugs just got harder for rural patients

In search for therapies for solid tumors, companies turn to claudin

AstraZeneca loses challenge to Medicare drug price negotiation

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

A Q&A with Aletha Maybank, AMA’s chief health equity officer

knowledge

focus

knowledge

focus